首页|醒脑静联合亚低温治疗重症脑出血的有效性及安全性

醒脑静联合亚低温治疗重症脑出血的有效性及安全性

扫码查看
目的 探讨醒脑静联合亚低温治疗重症脑出血的有效性及安全性。方法 选取 2020 年 1 月至 2022 年 1 月内黄县人民医院收治的 65 例重症脑出血患者,以随机数字表法分成研究组(n=32,醒脑静联合亚低温治疗)与对照组(n=33,亚低温治疗),比较两组临床疗效、神经功能、脑血肿和脑水肿体积、认知功能、日常生活能力及不良反应情况。结果 研究组治疗有效率(93。75%)高于对照组(75。76%),差异具有统计学意义(P<0。05);治疗后两组美国国立卫生研究院卒中量表(NIHSS)评分均降低,且研究组低于对照组,差异均有统计学意义(P<0。05);治疗后两组脑血肿、脑水肿体积均减小,且研究组小于对照组,差异均有统计学意义(P<0。05);治疗后两组简易智力状态检查量表(MMSE)、日常生活活动能力(ADL)量表评分均提高,且研究组高于对照组,差异均有统计学意义(P<0。05);研究组不良反应发生率(12。50%)与对照组(15。15%)比较差异无统计学意义(P>0。05)。结论 醒脑静联合亚低温应用于重症脑出血患者中,可提高临床疗效,改善神经功能,缩小脑血肿和脑水肿体积,提高患者认知功能和日常生活能力,安全性较高。
Efficacy and S afety of Xingnaojing Combined with Mild Hypothermia in the Treatment of Severe Cerebral Hemorrhage
Objective To investigate the efficacy and safety of Xingnaojing combined with mild hypothermia in the treatment of severe cerebral hemorrhage.Methods Sixty-five patients with severe cerebral hemorrhage admitted to Neihuang County People's Hospital from January 2020 to January 2022 were selected and randomly divided into a study group(n=32,treated with Xingnaojing combined with mild hypothermia)and a control group(n=33,treated with mild hypothermia).The clinical efficacy,neurological function,volumes of cerebral hematoma and cerebral edema,cognitive function,activities of daily living,and adverse reactions were compared between the two groups.Results The effective rate of treatment in the study group(93.75%)was higher than that in the control group(75.76%),with statistically significant differences(P<0.05).After treatment,the National Institutes of Health Stroke Scale(NIHSS)scores in both groups decreased,with the study group scoring lower than the control group,showing statistically significant differences(P<0.05).The volumes of cerebral hematoma and cerebral edema in both groups decreased after treatment,with the study group showing smaller volumes than the control group,with statistically significant differences(P<0.05).The Mini-Mental State Examination(MMSE)and Activities of Daily Living(ADL)scores in both groups increased after treatment,with the study group scoring higher than the control group,with statistically significant differences(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the study group(12.50%)and the control group(15.15%)(P>0.05).Conclusion The application of Xingnaojing combined with mild hypothermia in patients with severe cerebral hemorrhage can improve clinical efficacy,enhance neurological function,reduce the volumes of cerebral hematoma and cerebral edema,improve cognitive function and activities of daily living,and has high safety.

Xingnaojingmild hypothermiasevere cerebral hemorrhageefficacysafety

崔宝利、段勇升、苏永新

展开 >

内黄县人民医院 重症监护室,河南 安阳 456300

内黄县第二人民医院急诊科,河南 安阳 456300

内黄县人民医院重症医学科,河南 安阳 456300

醒脑静 亚低温 重症脑出血 有效性 安全性

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(10)